• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Effect of renal dysfunction on the individual components of the acyl-glucuronide futile cycle.

作者信息

Sallustio B C, Purdie Y J, Birkett D J, Meffin P J

机构信息

Department of Clinical Pharmacology, Flinders University of South Australia, Adelaide.

出版信息

J Pharmacol Exp Ther. 1989 Oct;251(1):288-94.

PMID:2795462
Abstract

Drugs which are cleared predominantly by forming acyl-glucuronides undergo a futile cycle in which plasma drug clearance is a function of the formation, hydrolysis and renal clearance of the glucuronide conjugate. The effect of impaired renal function, induced by uranyl nitrate administration, on each component of this process was studied in rabbits using diphenylacetic acid. Uranyl nitrate administration produced a decrease in creatinine clearance of approximately 70% and diphenylacetic acid plasma clearance of approximately 35%. In healthy rabbits the primary determinant of diphenylacetic acid net clearance was the very large component of glucuronide renal clearance (14.10 ml/min/kg) compared with glucuronide formation (4.79 ml/min/kg) or glucuronide hydrolysis (2.56 ml/min/kg). Uranyl nitrate treatment reduced both creatinine clearance and the glucuronide renal clearance by approximately 70%. Renal dysfunction had little effect on the hydrolysis clearance of the glucuronide, but reduced its formation clearance by 22.8%. The reduction in plasma clearance of diphenylacetic acid was a function of both the decrease in glucuronidation (60% contribution) and the decrease in renal clearance of the glucuronide (40% contribution). This study supports the futile cycle mechanism of reversible glucuronide conjugation for acyl-glucuronides in general, and provides a mechanism for the impairment of the plasma clearance in renal failure of drugs forming acyl-glucuronides.

摘要

相似文献

1
Effect of renal dysfunction on the individual components of the acyl-glucuronide futile cycle.
J Pharmacol Exp Ther. 1989 Oct;251(1):288-94.
2
Reduced clofibric acid clearance in renal dysfunction is due to a futile cycle.肾功能不全时氯贝酸清除率降低是由于无效循环所致。
J Pharmacol Exp Ther. 1983 Dec;227(3):732-8.
3
Diisopropylfluorophosphate increases clofibric acid clearance: supporting evidence for a futile cycle.
J Pharmacol Exp Ther. 1984 Jul;230(1):237-41.
4
A renal mechanism for the clofibric acid-probenecid interaction.
J Pharmacol Exp Ther. 1983 Dec;227(3):739-42.
5
Enantioselective disposition of 2-arylpropionic acid nonsteroidal anti-inflammatory drugs. I. 2-Phenylpropionic acid disposition.2-芳基丙酸类非甾体抗炎药的对映体选择性处置。I. 2-苯丙酸处置
J Pharmacol Exp Ther. 1986 Jul;238(1):280-7.
6
Possible mechanisms for reduced plasma clearance of diflunisal in rat experimental renal failure.
J Pharmacol Exp Ther. 1986 Sep;238(3):978-84.
7
Probenecid inhibits the renal clearance of frusemide and its acyl glucuronide.丙磺舒抑制速尿及其酰基葡萄糖醛酸苷的肾脏清除率。
Br J Clin Pharmacol. 1995 Jun;39(6):692-5.
8
Influence of renal failure in rats on the disposition of salicyl acyl glucuronide and covalent binding of salicylate to plasma proteins.
J Pharmacol Exp Ther. 1996 Jul;278(1):277-83.
9
Disposition of gemfibrozil and gemfibrozil acyl glucuronide in the rat isolated perfused liver.吉非贝齐及其酰基葡萄糖醛酸苷在大鼠离体灌注肝脏中的处置
Drug Metab Dispos. 1996 Sep;24(9):984-9.
10
Renal handling of drugs in renal failure. I: Differential effects of uranyl nitrate- and glycerol-induced acute renal failure on renal excretion of TEAB and PAH in rats.肾衰竭时药物的肾脏处理。I:硝酸铀酰和甘油诱导的急性肾衰竭对大鼠TEAB和PAH肾脏排泄的不同影响。
J Pharmacol Exp Ther. 1988 Sep;246(3):896-901.

引用本文的文献

1
Population pharmacokinetic modelling of febuxostat in healthy subjects and people with gout.健康受试者和痛风患者非布司他的群体药代动力学模型研究。
Br J Clin Pharmacol. 2022 Dec;88(12):5359-5368. doi: 10.1111/bcp.15462. Epub 2022 Jul 28.
2
A Comprehensive Whole-Body Physiologically Based Pharmacokinetic Model of Dabigatran Etexilate, Dabigatran and Dabigatran Glucuronide in Healthy Adults and Renally Impaired Patients.达比加群酯、达比加群和达比加群葡萄糖醛酸在健康成年人和肾功能损害患者中的全面全身体生理药代动力学模型。
Clin Pharmacokinet. 2019 Dec;58(12):1577-1593. doi: 10.1007/s40262-019-00776-y.
3
Clinical Pharmacokinetics and Pharmacodynamics of Febuxostat.
非布司他的临床药代动力学与药效学
Clin Pharmacokinet. 2017 May;56(5):459-475. doi: 10.1007/s40262-016-0466-4.
4
Measurement of renal function during drug development.药物研发过程中的肾功能测量。
Br J Clin Pharmacol. 2002 Jul;54(1):87-95. doi: 10.1046/j.1365-2125.2002.01625.x.
5
Stereoselective disposition of flurbiprofen in uraemic patients.氟比洛芬在尿毒症患者体内的立体选择性分布
Br J Clin Pharmacol. 1992 Apr;33(4):377-83. doi: 10.1111/j.1365-2125.1992.tb04055.x.
6
Glucuronidation of drugs. A re-evaluation of the pharmacological significance of the conjugates and modulating factors.
Clin Pharmacokinet. 1992 Oct;23(4):292-310. doi: 10.2165/00003088-199223040-00005.